367 related articles for article (PubMed ID: 234996)
1. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
2. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
[TBL] [Abstract][Full Text] [Related]
3. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
5. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
Gordon EM; Ratnoff OD; Jones PK
J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
[TBL] [Abstract][Full Text] [Related]
6. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
Thorisdottir H; Ratnoff OD; Maniglia AJ
J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
[TBL] [Abstract][Full Text] [Related]
7. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
8. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
Saito H
J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
[TBL] [Abstract][Full Text] [Related]
9. The interaction of Hageman factor and immune complexes.
Cochrane CG; Wuepper KD; Aiken BS; Revak SD; Spiegelberg HL
J Clin Invest; 1972 Oct; 51(10):2736-45. PubMed ID: 5056666
[TBL] [Abstract][Full Text] [Related]
10. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
Saito H; Ratnoff OD; Marshall JS; Pensky J
J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
[TBL] [Abstract][Full Text] [Related]
11. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
[TBL] [Abstract][Full Text] [Related]
12. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
[TBL] [Abstract][Full Text] [Related]
13. Contact activation of human plasma prorenin in vitro.
Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
[TBL] [Abstract][Full Text] [Related]
14. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
Soulier JP; Gozin D
Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
[TBL] [Abstract][Full Text] [Related]
15. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
Revak SD; Cochrane CG; Griffin JH
J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
[TBL] [Abstract][Full Text] [Related]
16. C-1 inactivator and cold-promoted activation of factor VII.
van Royen EA; Lohman S; Voss M; Pondman KW
J Lab Clin Med; 1978 Aug; 92(2):152-63. PubMed ID: 681808
[TBL] [Abstract][Full Text] [Related]
17. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
Espana F; Aznar J; Estelles A
J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
[TBL] [Abstract][Full Text] [Related]
18. Activation of Hageman factor by collagen.
Wilner GD; Nossel HL; LeRoy EC
J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
20. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
